Kwangdong Pharmaceutical has established an 'Ethics Day' and elevated its Compliance Committee to strengthen its compliance management system.
On June 2, Kwangdong announced the appointment of compliance officers and held a ceremony to award the Compliance Committee's charter. The company also conducted training for internal auditors and compliance culture establishment as part of the committee's initiatives.
The previous anti-corruption internal audit organization, known as the Anti-Corruption Subcommittee, has been upgraded to the Compliance Committee. The committee plans to enhance internal control functions through compliance monitoring, ISO internal audits, and risk assessment management training.
Kwangdong has consistently strengthened its compliance management system by upgrading its Compliance Division to a departmental organization and placing it directly under the CEO. In 2023, the company obtained integrated certification for its Anti-Corruption Management System (ISO 37001) and Compliance Management System (ISO 37301).
ISO 37001 and ISO 37301 are standards established by the International Organization for Standardization (ISO) that are awarded to organizations with systems capable of identifying and controlling corruption and compliance risks in advance.
A Kwangdong representative stated, "We will emphasize the importance of responsible work performance and spread a culture of compliance throughout the company."
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.